Sort
48,018 grants matching “immunotherapy”
Structure-function studies of LAG3 interactions with antibodies and cellular ligands
$549,962Vincent Christopher Luca · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
$549,873Paul E Kinahan · University Of Washington · U24 · FY2024 · CA
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab
$549,804Edith A Perez · Mayo Clinic Jacksonville · R01 · FY2012 · CA
SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT
$549,675Pal Ranajit · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated Neurotoxicity
$549,663Juliane Gust · Seattle Children'S Hospital · R37 · FY2024 · CA
Delineating Functional Immunity via Image-Guided PET
$549,663Nerissa Therese Viola · Wayne State University · R37 · FY2019 · CA
CAREER: Systems Immunology Approach to Memory T Cell Immune Engineering
$549,648Jenny Jiang · University Of Texas At Austin · · FY2017 · ENG
Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity
$549,598David G Denardo · Washington University · R01 · FY2023 · CA
Multiscale analysis of metabolic inflammation as a driver of breast cancer
$549,519Gerald V Denis · Boston University Medical Campus · U01 · FY2023 · CA
Supramolecular biomaterials for tuning the inflammatory properties of the complement system
$549,485Joel H Collier · Duke University · R01 · FY2024 · AI
Supramolecular biomaterials for tuning the inflammatory properties of the complement system
$549,485Joel H Collier · Duke University · R01 · FY2023 · AI
Program control of CD8+ T cell response to tumors and tumor memory
$549,460Dorina Avram · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Southern Nevada Cancer Research Foundation--CCOP
$549,418Southern Nevada Cancer Research Fdn · U10 · FY2003 · CA
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
$549,341Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
$549,341Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Characterizing Immunogenetics in Type 1 Diabetes
$549,316Lue Ping Na Zhao · Fred Hutchinson Cancer Center · R01 · FY2024 · DK
Elucidating the Immune Suppressive Mechanism of SIGLEC-15 in the Tumor Microenvironment
$549,292Jun Wang · New York University School Of Medicine · R01 · FY2024 · CA
Molecular and Cellular Immunology
$549,173Jason G. Cyster · University Of California, San Francisco · T32 · FY2022 · AI
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
$549,102Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2017 · CA
Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity
$549,025David G Denardo · Washington University · R01 · FY2021 · CA
Characterization of Pigmentary Disorders and Melanoma Targeting
$548,960Vincent J Hearing · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinoma
$548,908Adam I Marcus · Emory University · P01 · FY2022 · CA
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
$548,899Zihai Li · Ohio State University · R01 · FY2025 · CA
Personalized, antigen-directed immunotherapy delivered to lymph nodes
$548,896Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · CA
ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE
$548,805Heather L Stevenson · University Of Texas Med Br Galveston · R01 · FY2023 · DK